BCTXW

BriaCell Therapeutics Corp. BCTXW

BCTXW
BriaCell Therapeutics Corp. OCEA
Ocean Biomedical, Inc. SABS
SAB Biotherapeutics, Inc. NUWE
Nuwellis, Inc. PKBO
Peak Bio, Inc. VINC
Vincerx Pharma, Inc. PETV
PetVivo Holdings, Inc. LIXT
Lixte Biotechnology Holdings, Inc. SYRS
Syros Pharmaceuticals, Inc. KTTA
Pasithea Therapeutics Corp.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BCTXW OCEA SABS NUWE PKBO VINC PETV LIXT SYRS KTTA
6M -60.36 % -85.71 % 117.32 % -80.80 % 150.00 % -75.00 % 47.50 % 439.53 % -96.36 % 58.42 %
YTD -90.87 % -99.83 % 4.85 % -95.73 % -91.50 % -99.72 % 57.33 % 89.56 % -99.65 % -59.56 %
1Y -91.54 % -99.84 % -9.11 % -95.16 % -71.84 % -99.67 % 133.74 % 101.35 % -99.61 % -55.45 %
3Y -98.61 % -99.99 % -43.60 % -99.98 % -99.77 % -99.93 % -42.44 % -17.48 % -99.97 % -90.11 %
5Y -96.51 % -99.99 % -96.17 % -100.00 % -99.77 % -100.00 % -91.17 % -87.77 % -100.00 % -98.34 %
10Y -96.51 % -99.99 % -96.17 % -100.00 % -99.77 % -99.99 % -90.17 % -81.04 % -100.00 % -98.34 %
From the beginning -96.51 % -99.99 % -96.17 % -100.00 % -99.77 % -99.99 % -91.15 % -99.84 % -100.00 % -98.34 %

Dividend